GlaxoSmithKline is recalling prescription-only versions of its heartburn medicine Zantac globally after the U.S. Food and Drug Administration found “unacceptable” levels of a potential carcinogen in ...
The FDA on Thursday awarded six new Commissioner’s National Priority Vouchers for a variety of conditions including lung cancer, rectal cancer and weight loss.
GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback